- Volume is elevated versus the 13-week average, confirming attention.
XBRK
MCE
Week ended 07 Aug 2026
Weekly Investor Report
Braskem S.A. · Basic Materials · Chemicals
Latest close
0.97 EUR
-3.0%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -36.0% below the Trend Line and sits at 0.0% of its 52-week range. The latest completed week returned -3.0%, after a -14.2% four-week move. The latest news-sentiment score is 47/100.
Setup score
25
out of 100
Latest Close
0.97 EUR
7 Aug 2026
1W Return
-3.0%
latest completed week
4W Return
-14.2%
short-term follow-through
12W Return
-52.0%
quarterly tape
Trend Breadth
34.6%
18 of 52 weeks active
Volume Ratio
2.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-3.0%
Latest completed week; four-week move -14.2%.
Indicator stack
19/27
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 35.33%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
47/100
11 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -36.0% below the Trend Line and sits at 0.0% of its 52-week range. The latest completed week returned -3.0%, after a -14.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.0x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1512-week average 0.38
12-week confirmation
Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.15Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -14.2% over four weeks, -52.0% over 12 weeks, and -28.7% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year18
Trend breadth34.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.28Latest activity-pressure read.
Pressure change-1.1%Four-week change in activity pressure.
Leadership-40.51Latest relative-leadership reading.
RS change-31.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment47/100
Weighted news tone is neutral across 11 relevant articles.
0 positive · 10 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-55.9%Distance below the 52-week high.
13-week volatility11.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher7 of 2615 weeks finished lower.
Best week+32.1%Week of 6 Mar.
Worst week-23.8%Week of 19 Jun.
Latest week-3.0%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains2
Flat weeks4
Modest losses6
Sharp losses9
Recent vol11.0%13-week weekly-return volatility.
Base vol9.4%52-week weekly-return volatility.
Up/down split20/27Count of positive and negative weeks in the 52-week window.
Average skew8.5% / -6.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorES Basic Materials
4-week rank14 / 15
Group average-0.7%
Trend breadth53.3%
Trend53.3%active weekly trend signals
MD53.3%positive activity pressure
RS46.7%positive relative leadership
Four-week leaders
IndustryES Chemicals
4-week rank2 / 2
Group average-6.9%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD50.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape27/100
Trend, activity pressure, participation, and risk combine to a 27/100 tape read.
Indicator analysis28/100Latest 12-week confirmation: trend 4/12, activity pressure 3/12, relative leadership 2/12.
Activity pressure 0.15; No reversal markers Next-Week ExpectancyNegative 35.33%Next-week expectancy is negative with a 35.33% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment47/100Weighted news tone is neutral across 11 relevant articles.
Braskem (NYSE: BAK) executive files initial Form 3 insider ownership statement Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.97 EUR | -3.0% | 1.52 EUR | 2.43 EUR | -1.28 | -40.51 | 18.0K | Off |
| 31 Jul 2026 | 1.00 EUR | -5.7% | 1.52 EUR | 2.45 EUR | -1.28 | -38.09 | 1.5K | Off |
| 24 Jul 2026 | 1.06 EUR | -6.2% | 1.53 EUR | 2.48 EUR | -1.33 | -34.45 | 277 | Off |
| 17 Jul 2026 | 1.13 EUR | 0.0% | 1.54 EUR | 2.50 EUR | -1.32 | -29.48 | 0 | Off |
| 10 Jul 2026 | 1.13 EUR | 5.6% | 1.54 EUR | 2.52 EUR | -1.26 | -30.70 | 33.2K | Off |
| 3 Jul 2026 | 1.07 EUR | -1.8% | 1.54 EUR | 2.55 EUR | -1.27 | -36.64 | 0 | Off |
| 26 Jun 2026 | 1.09 EUR | -10.7% | 1.55 EUR | 2.57 EUR | -1.00 | -34.78 | 3.1K | Off |
| 19 Jun 2026 | 1.22 EUR | -23.8% | 1.55 EUR | 2.60 EUR | -0.66 | -27.41 | 5.3K | Off |
| 12 Jun 2026 | 1.60 EUR | 3.2% | 1.56 EUR | 2.63 EUR | -0.18 | -2.94 | 0 | On |
| 5 Jun 2026 | 1.55 EUR | -13.4% | 1.54 EUR | 2.65 EUR | 0.22 | -4.49 | 9.1K | On |
| 29 May 2026 | 1.79 EUR | -12.3% | 1.53 EUR | 2.67 EUR | 0.21 | 9.48 | 10.0K | On |
| 22 May 2026 | 2.04 EUR | 1.0% | 1.51 EUR | 2.69 EUR | 0.03 | 26.65 | 20.6K | On |
| 15 May 2026 | 2.02 EUR | 23.9% | 1.47 EUR | 2.71 EUR | -0.22 | 27.86 | 18.5K | On |
| 8 May 2026 | 1.63 EUR | 8.7% | 1.44 EUR | 2.72 EUR | -0.41 | 1.62 | 1.8K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.